Loading…

Variable Impact on Mortality of AIDS-Defining Events Diagnosed during Combination Antiretroviral Therapy: Not All AIDS-Defining Conditions Are Created Equal

Background. The extent to which mortality differs following individual acquired immunodeficiency syndrome (AIDS)-defining events (ADEs) has not been assessed among patients initiating combination antiretroviral therapy. Methods. We analyzed data from 31,620 patients with no prior ADEs who started co...

Full description

Saved in:
Bibliographic Details
Published in:Clinical infectious diseases 2009-04, Vol.48 (8), p.1138-1151
Main Authors: Mocroft, Amanda, Sterne, Jonathan A C, Egger, Matthias, May, Margaret, Grabar, Sophie, Furrer, Hansjakob, Sabin, Caroline, Fatkenheuer, Gerd, Justice, Amy, Reiss, Peter, d'Arminio Monforte, Antonella, Gill, John, Hogg, Robert, Bonnet, Fabrice, Kitahata, Mari, Staszewski, Schlomo, Casabona, Jordi, Harris, Ross, Saag, Michael
Format: Article
Language:English
Subjects:
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background. The extent to which mortality differs following individual acquired immunodeficiency syndrome (AIDS)-defining events (ADEs) has not been assessed among patients initiating combination antiretroviral therapy. Methods. We analyzed data from 31,620 patients with no prior ADEs who started combination antiretroviral therapy. Cox proportional hazards models were used to estimate mortality hazard ratios for each ADE that occurred in >50 patients, after stratification by cohort and adjustment for sex, HIV transmission group, number of antiretroviral drugs initiated, regimen, age, date of starting combination antiretroviral therapy, and CD4+ cell count and HIV RNA load at initiation of combination antiretroviral therapy. ADEs that occurred in
ISSN:1058-4838
1537-6591
1537-6591
DOI:10.1086/597468